ESC 365 - The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Conclusion.

ACVC Premium Access

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Conclusion.

Session: The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Topic: Other

Speaker: Professor M. Valgimigli (Lugano, CH)

Event: Acute Cardiovascular Care 2019

Congress Presentation

Add to my library

About the speaker

Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

31 presentations

6 followers

4 more presentations in this session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Introduction.

Speaker: Professor P. Vranckx (Hasselt, BE)

Design, statistics, and pitfalls of a pragmatic clinical trial.

Speaker: Professor K. Rowan (London, GB)

What are the implications of GLOBAL LEADERS for clinical practice?

Speaker: Professor K. Huber (Vienna, AT)

Compliment the Investigators Assessment: the GLOBAL LEADERS Adjudication SubSTudy.

Speaker: Associate Professor A. Franzone (Naples, IT)

Access the full session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Speakers: Professor M. Valgimigli, Professor P. Vranckx, Professor K. Rowan, Professor K. Huber, Associate Professor A. Franzone

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources